The Effect Of White Noise And Therapeutic Touch On Pain And Physiological Parameters In Premature Infants
NCT ID: NCT05395208
Last Updated: 2022-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2021-06-01
2022-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis 0: The application of therapeutic touch with white noise during peripheral intravenous catheter intervention in premature infants has no effect on the level of pain.
Hypothesis 1: White noise-accompanied therapeutic touch application reduces pain level during peripheral intravenous catheter intervention in premature infants.
Hypothesis 2: The therapeutic touch application accompanied by white noise during peripheral intravenous catheter intervention in premature infants positively affects physiological parameters.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
White Noise and Therapeutic Touch on Pain and Comfort Level in Newborns During Heel Lance
NCT05524337
Investigation of the Effect of White Noise Listening on Pain and Comfort During Invasive Interventions in Newborns
NCT05103800
The Effect of Music, White Noise and Heart Sound on Neonatal Pain
NCT05828420
The Effect of White Noise and Swaddling on Pain, Heart Rate, and Oxygen Saturation in Term İnfants Undergoing Eye Examinations
NCT06535984
Maternal Heartbeat Sounds and Therapeutic Touch on Heart Rate,Comfort and Behavior in Newborns
NCT06724328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As a data collection tool; "Baby Follow-up Form" was used in which some descriptive features of the baby and NIPS and physiological parameter measurements were evaluated.
Application:
The data of the study were collected using simple random sampling method. The newborns to be included in the study were divided into two groups as the intervention group and the control group. The data were determined according to the odd and even numbered days of the calendar between the research dates, and the babies born on the odd numbered days of the calendar were included in the white noise therapeutic touch group (intervention group), and the babies born on the even numbered days of the calendar were included in the control group. The environmental conditions in the two groups were regulated in the same way. The application was carried out with a research nurse performing therapeutic touch, an observer nurse and a practitioner nurse.
Intervention Group (n=40) :
* Camera recording was started 5 minutes before intravenous catheter intervention, vital signs and pain were evaluated.
* Therapeutic touch application with white noise was started.
* Vital signs and pain were evaluated during intravenous catheterization.
* Vital signs and pain were evaluated when the intravenous catheter intervention was terminated and 5 minutes later, and the camera recording was stopped.
Control Group (n=41):
* Camera recording was started 5 minutes before the intravenous catheter intervention, vital signs and pain were evaluated.
* No application was made other than intravascular catheter intervention.
* Vital signs and pain were evaluated during intravenous catheterization.
* Vital signs and pain were evaluated when the intravenous catheter intervention was terminated and 5 minutes later, and the camera recording was stopped.
Universe and Research Example Newborns treated at Zeynep Kamil Gynecology and Pediatrics Training and Research Hospital Neonatal Intensive Care Service between June 2021 and January 2022 constitute the population of the research. The sample of the study consisted of 85 newborns meeting the sampling criteria of the study in the Neonatal Intensive Care Service of Zeynep Kamil Gynecology and Pediatrics Training and Research Hospital.
Sampling selection criteria of the infant;
* 32-36. to be born in gestational weeks,
* The need for noninvasive mechanical ventilation,
* Absence of congenital anomalies,
* Appropriate cognitive level and motor development of the newborn,
* Does not prevent the opening of the vascular access,
* Not using narcotic, sedative opioid and anticonvulsant drugs,
* No pharmacological intervention for the baby's pain during the procedure,
* Parents sign the informed consent form. Dependent Variables: The newborn's heart rate, respiratory rate, oxygen saturation, body temperature, blood pressure, pain score are the dependent variables.
Independent Variables: The sex of the newborn, gestational age, mode of delivery, weight, height, head circumference, type of feeding, type of noninvasive mechanical ventilation support constitute the independent variables.
Sample size was determined by power analysis. In the study, the power of the sample was calculated with the G\*Power 3.1 program. The amount of type I error was 0.05 and the power of the test =0.80 (α=0.05, 1-β=0.80, effect size:0.6), while the minimum sample size (36 newborns in each group) was 72. newborns Considering the losses that may arise from the sample for any reason during the study period, it is planned to take 10% more of the power analysis result. In the study, 40 newborns were included in the intervention group (therapeutic touch with white noise) and 41 newborns in the control group.
Data Collection Written permission from the ethics committee of Zeynep Kamil Gynecology and Pediatrics Training and Research Hospital (Annex-3) and research permission from the Istanbul Governorship Provincial Health Directorate (Annex-4) for the collection of pre-research data. After explanations were given to the families of the newborns who agreed to participate in the study, and to the families of the newborns who met the sample selection criteria for the purpose of the study, verbal and written informed consent was obtained from the families of the newborns who agreed to participate in the study (Annex-1). During the research, personal information will be kept confidential and care will be taken for their privacy. The data of the study were collected between June 2020 and January 2021. The application time of each data and filling the data collection forms took an average of 20-25 minutes.
Evaluation of Data The data of the study were analyzed with appropriate statistical methods using the SPSS (Statistical Package for the Social Science) 22.0 package program. In the evaluation of the data, percentage, number, mean and standard deviation were used as descriptive statistical methods, and frequency and percentage distributions of the data were given. The relationship between the variables measured at the categorical level was evaluated with the Pearson chi-square test. Whether the research variables showed normal distribution or not was examined by paired test and independent group t test. The significance level was 0.05; It was stated that there was a significant difference in cases with p\<0.05, and there was no significant difference in cases with p\>0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapeutic touch group accompanied by white noise
* Camera recording was started 5 minutes before intravenous catheter intervention, vital signs and pain were evaluated.
* Therapeutic touch application with white noise was started.
* Vital signs and pain were evaluated during intravenous catheterization.
* Vital signs and pain were evaluated when the intravenous catheter intervention was terminated and 5 minutes later, and the camera recording was stopped.
Therapeutic touch group accompanied by white noise
During the intravenous catheter intervention, approximately 15-20 minutes of white noise was applied with therapeutic touch.
Control group
* Camera recording was started 5 minutes before the intravenous catheter intervention, vital signs and pain were evaluated.
* No application was made other than intravascular catheter intervention.
* Vital signs and pain were evaluated during intravenous catheterization.
* Vital signs and pain were evaluated when the intravenous catheter intervention was terminated and 5 minutes later, and the camera recording was stopped.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapeutic touch group accompanied by white noise
During the intravenous catheter intervention, approximately 15-20 minutes of white noise was applied with therapeutic touch.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newborns between 32-36 weeks,
* Not having a life-threatening disease,
* No congenital anomalies,
* Appropriate cognitive level and motor development of the newborn,
* The newborn does not have a physical problem,
* Parents' willingness to participate in the research,
Exclusion Criteria
* Having a condition that prevents vascular access,
* Those who have circulation problems in the body,
* Using narcotic, sedative opioid and anticonvulsant drugs
* Pharmacological intervention application for the baby's pain during the procedure
32 Weeks
36 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Okan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zeynep Uysal
NURSE
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülzade Uysal, Assoc. Dr.
Role: STUDY_DIRECTOR
Okan Üniversitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Home/Work
Istanbul, Üsküdar, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/99
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.